Financial restatement

Search documents
The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges
Globenewswireยท 2025-07-30 22:48
Core Viewpoint - The Joint Corp. plans to restate its previously issued financial statements for 2024 and the first quarter of 2025 due to errors related to the impairment of assets held for sale, which will affect the reported net loss and carrying value of these assets [1][2][4][6]. Financial Impact - For the year ended December 31, 2024, the correction is expected to reduce the previously reported loss from discontinued operations by approximately $2.2 million, leading to a decrease in net loss and an increase in the carrying value of assets held for sale by the same amount [4]. - For the quarter ended March 31, 2025, the correction is anticipated to increase previously reported income from discontinued operations by approximately $0.5 million, resulting in a cumulative increase in the carrying value of assets held for sale by approximately $2.7 million [6]. Adjusted EBITDA - The adjustments for both the year ended December 31, 2024, and the quarter ended March 31, 2025, are not expected to impact Adjusted EBITDA or cash positions [5][7]. Internal Controls - The company is evaluating the impact of the identified errors on its internal control over financial reporting, expecting to conclude that there will be a material weakness in these controls during the applicable periods [8]. Company Overview - The Joint Corp. is the largest franchisor of chiropractic care in the U.S., operating over 950 locations and facilitating more than 14 million patient visits annually [10]. - The company has been recognized in various industry rankings, including Franchise Times' "Top 400" and Entrepreneur's "Franchise 500" [10]. Business Structure - The Joint Corp. operates as a franchisor and manages clinics in several states, providing management services to affiliated chiropractic practices [11].